Work

Discovery of a new series of PI3K-δ inhibitors from Virtual Screening

Year: 2021

Type: article

Source: Bioorganic & Medicinal Chemistry Letters

DOI: 10.1016/j.bmcl.2021.128046

Authors: Xavier Fradera, Qiaolin Deng, Abdelganhi Achab, Yudith Garcia, Solomon D. Kattar, Meredeth A. McGowan, Joey L. Methot, Kevin Wilson, Hua Zhou, Lynsey Shaffer, Peter Goldenblatt, Vincent Tong, Martin A Augustin, Michael D. Altman, Charles A. Lesburg, Sanjiv Shah, Jason D. Katz

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3153170011

FWCI: 0.157

Cites: 20

Cited by: 5

Related to: 10